Praxis Precision Medicines, Inc. PRAX Cash Flow Statement
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| -$303.27M-65.9% | -$182.82M-48.3% | -$123.28M+42.4% | -$214.03M-28.1% | ||
| $140K-60.9% | $358K-17.1% | $432K+3.1% | $419K+130% | ||
| $33.94M-17.9% | $41.36M+66.4% | $24.86M-13.1% | $28.59M+26.0% | ||
| -$249.07M-89.0% | -$131.76M-18.6% | -$111.14M+39.9% | -$185.04M-48.6% | ||
| —— | $0-100% | $50K-88.7% | $444K-57.7% | ||
| -$329.04M— | —— | —— | $96.89M— | ||
| $702.17M+36.5% | $514.32M+460% | $91.87M+778% | $10.47M-90.3% | ||
| $141.96M+0.7% | $140.91M— | —— | -$84.09M— | ||
| -$249.12M-89.1% | -$131.76M-18.5% | -$111.19M+40.1% | -$185.49M-47.7% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does Praxis Precision Medicines, Inc. generate?
- Praxis Precision Medicines, Inc. (PRAX) generated -$282.2M in operating cash flow over the trailing twelve months.
- What is Praxis Precision Medicines, Inc.'s free cash flow?
- After $118.0K of capital expenditures, Praxis Precision Medicines, Inc.'s free cash flow was -$282.3M over the trailing twelve months, down 72.3% year over year.
- Where does Praxis Precision Medicines, Inc.'s cash flow data come from?
- Every line is extracted from Praxis Precision Medicines, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.